Insulin Resistance, Obesity, and Progression

Colorectal cancer is one of the most common malignant tumors worldwide and is increasingly linked to metabolic disorders such as insulin resistance and obesity. New epidemiological data show significant shifts in incidence and age distribution, underscoring the importance of preventive and metabolically oriented approaches. In particular, the interactions between metabolism, inflammation, and tumor biology are becoming a greater focus of research.